ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Regular Plan

Other Plans and Options
  • 0.33 %Nav, as on 14-10-2024

  • Previous Nav

  • Net Change on 14-10-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 0.98 15.52 62.52 22.45 33.12 24.40
BSE Health Care - TRI 0.73 16.54 58.57 19.83 30.30 16.49
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 62.52 22.45 33.12 1.92 4,987.49
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 51.06 19.37 30.53 1.81 8,768.67
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 52.28 21.82 31.37 1.95 3,346.13
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 53.53 18.22 31.84 1.93 2,793.61
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 56.22 20.55 29.39 2.13 1,208.25
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 57.68 19.15 30.57 2.24 1,201.38

Fund Holdings as on 30-September-2024

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Cipla Ltd.

  • TREPS

  • Lupin Ltd.

  • Gland Pharma Ltd.

  • Aurobindo Pharma Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Divi's Laboratories Ltd.

  • Healthcare Global Enterprises Ltd.

  • Medplus Health Services Ltd

  • Zydus Lifesciences Ltd.

  • Astrazeneca Pharma India Ltd.

  • Shilpa Medicare Ltd.

  • Aster DM Healthcare Ltd.

  • Fortis Healthcare Ltd.

  • Pfizer Ltd.

  • Alkem Laboratories Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Krishna Institute of Medical Sciences

  • Medi Assist Healthcare Services Ltd

  • Windlas Biotech Ltd.

  • FDC Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Max Financial Services Ltd.

  • Thyrocare Technologies Ltd.

  • Mankind Pharma Ltd

  • Glenmark Life Sciences Ltd

  • Krsnaa Diagnostics Ltd.

  • Wockhardt Ltd.

  • Star Health & Allied Insurance

  • Vijaya Diagnostic Centre Ltd.

  • Fine Organic Industries Ltd.

  • Syngene International Ltd.

  • Emcure Pharmaceuticals Ltd.

  • Blue Jet Healthcare Ltd.

  • Procter & Gamble Health Ltd.

  • Vinati Organics Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Unichem Laboratories Ltd.

  • Hikal Ltd.

  • Aarti Drugs Ltd.

  • Cash Margin - Derivatives

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Chemicals

  • Finance - Others

  • Insurance

View More

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹4,987.49 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.13(0.33%)yesterday to ₹39.28.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100